Association between MHC class II alleles and clearance of circulating hepatitis c virus

Journal of Infectious Diseases

Volumn 178, Issue 1, 1998, Pages 39-44

  Minton, E J ^a   Smillie, D ^b   Neal, K R ^b   Irving, W L ^b   Underwood, J C E ^b   James, V ^b  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HLA TYPING; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY;

EID: 0031845494     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515599     Document Type: Article

References (20)

1. Follett EAC, Dow BC, McOmish F, et al. HCV confirmatory testing of blood donors. Lancet 1991;338:1024.
2. Alter MJ, Margolis HS, Krawczynski K. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992;327: 1899-905.
3. Van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344:1475-9.
4. Houghton M. Hepatitis C viruses. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology, 3d ed. Philadephia: Lippincott-Raven, 1996.
5. Chazouilleres O, Kim M, Combs C. Quantitation of hepatitis C virus RNA in liver transplant patients. Gastroenterology 1994;106:994-9.
6. Gruber A, Lundberg LG, Bjorkholm M. Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy. J Intern Med 1993; 234:223-5.
7. Peano G, Menardi G, Ponzetto A, Fenoglio LM. HLA-DR5 antigen - a genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med 1994;154:2733-6.
8. Kuzushita N, Hayashi N, Katayama K, et al. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels. J Med Virol 1996;48:1-7.
9. Zavaglia C, Bortolon C, Ferrioli G, et al. HLA typing in chronic type B, D and C hepatitis. J Hepatol 1996;24:658-65.
10. Aikawa T, Kojima M, Onishi H, et al. HLA DRB1 and DQBI alleles and haplotypes influencing the progression of hepatitis C. J Med Virol 1996; 49:274-8.
11. Czaja AJ, Carpenter H, Santrach PJ, Moore SB. DR human leucocyte antigens and disease severity in chronic hepatitis C. J Hepatol 1996; 24:666-73.
12. Congia M, Clemente MG, Dessi C, et al. HLA class II genes in chronic hepatitis C virus infection and associated immunological disorders. Hepatology 1996;24:1338-41.
13. Tibbs C, Donaldson P, Underhill J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQAI*03 allele confers protection from chronic HCV infection in northern European caucasoids. Hepatology 1996;24: 1342-5.
14. Pawlotsky JM, Fleury A, Choukroun V, et al. Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV-RIBA. J Clin Microbiol 1994;32:1357-9.
15. Irving WL, Day S, Eglin RP, et al. Hepatitis C in blood donors. Lancet 1993;341:835-6.
16. Kimura A, Sasazuki T. Reference protocol for the HLA DNA typing technique. In: Aizawa M, Sasazuki T, eds. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford, UK: Oxford University Press, 1992.
17. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
18. Hill AVS. HLA and infection. J R Coll Physicians Lond 1992;26:11-6.
19. Hosmer DW, Lemeshaw S. Applied logistic regression. New York: John Wiley and Sons, 1989.
20. Yamakawa Y, Sata M, Suzuki H, Noguchi S, Tanikawa K. Higher elimination rate of hepatitis C virus among women. J Viral Hepatitis 1996;3: 317-22.